Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		157,166,360
Beginning balance at Dec. 31, 2023	$ 356,892	$ 2	$ 1,076,508	$ 80	$ (719,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	25,066		25,066
Exercise of stock options (in shares)		780,998
Exercise of stock options	252		252
Vesting of restricted stock units (in shares)		1,748,589
Shares withheld related to net share settlement of equity awards (in shares)		(1,142,081)
Shares withheld related to net share settlement of equity awards	(11,712)		(11,712)
Repurchases of common stock (in shares)		(4,962,145)
Repurchases of common stock	(55,511)		(55,511)
Other comprehensive loss	(154)			(154)
Net loss	(18,339)				(18,339)
Ending balance (in shares) at Mar. 31, 2024		153,591,721
Ending balance at Mar. 31, 2024	296,494	$ 2	1,034,603	(74)	(738,037)
Beginning balance (in shares) at Dec. 31, 2024		147,484,280
Beginning balance at Dec. 31, 2024	197,394	$ 1	1,002,390	(11)	(804,986)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	19,661		19,661
Exercise of stock options (in shares)		148,557
Exercise of stock options	36		36
Vesting of restricted stock units (in shares)		1,554,329
Vesting of restricted stock units	0
Shares withheld related to net share settlement of equity awards (in shares)		(702,060)
Shares withheld related to net share settlement of equity awards	(5,957)		(5,957)
Other comprehensive loss	(4)			(4)
Net loss	(1,771)				(1,771)
Ending balance (in shares) at Mar. 31, 2025		148,485,106
Ending balance at Mar. 31, 2025	$ 209,359	$ 1	$ 1,016,130	$ (15)	$ (806,757)